Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Sep;10(3):417–420. doi: 10.1128/aac.10.3.417

Bacteriocin Production by Neisseria gonorrhoeae

William D Lawton 1, Mary Ann Bellinger 1, Marion Schling 1, Hassan A Gaafar 1
PMCID: PMC429763  PMID: 825028

Abstract

Seventeen apparently unrelated isolates of Neisseria gonorrhoeae out of 2,123 tested produced a diffusible growth-inhibitory substance against other gonococci. The inhibitor was destroyed by trypsin, not blocked by bovine serum albumin, and not soluble in chloroform-methanol; each isolate was resistant to the inhibitor it produced. Thus, the substance differs from previously described gonococcal inhibitors, and since it fits the description of a bacteriocin we designated it gonocin. The use of gonocin for typing was complicated by the observation that susceptibility to gonocin appears to depend on the gonococcal colony type.

Full text

PDF
417

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen N. C., Hipp S. S., Lawton W. D., Gaafar H. A. Gonogrow, an improved, selective medium for the isolation of Neisseria gonorrhoeae. Health Lab Sci. 1974 Jul;11(3):173–177. [PubMed] [Google Scholar]
  2. Counts G. W., Seeley L., Beaty H. N. Identification of an epidemic strain of Neisseria meningitidis by bacteriocin typing. J Infect Dis. 1971 Jul;124(1):26–32. doi: 10.1093/infdis/124.1.26. [DOI] [PubMed] [Google Scholar]
  3. Flynn J., McEntegart M. G. Bacteriocins from Neisseria gonorrhoeae and their possible role in epidemiological studies. J Clin Pathol. 1972 Jan;25(1):60–61. doi: 10.1136/jcp.25.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. GARBUS J., DELUCA H. F., LOOMANS M. E., STRONG F. M. The rapid incorporation of phosphate into mitochondrial lipids. J Biol Chem. 1963 Jan;238:59–63. [PubMed] [Google Scholar]
  5. KELLOGG D. S., Jr, PEACOCK W. L., Jr, DEACON W. E., BROWN L., PIRKLE D. I. NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION. J Bacteriol. 1963 Jun;85:1274–1279. doi: 10.1128/jb.85.6.1274-1279.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kingsbury D. T. Bacteriocin production by strains of Neisseria meningitidis. J Bacteriol. 1966 May;91(5):1696–1699. doi: 10.1128/jb.91.5.1696-1699.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Knapp J. S., Falkow S., Holmes K. K. Reevaluation of bacteriocinogeny in Neisseria gonorrhoeae. J Clin Pathol. 1975 Apr;28(4):274–278. doi: 10.1136/jcp.28.4.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Walstad D. L., Reitz R. C., Sparling P. F. Growth inhibition among strains of Neisseria gonorrhoeae due to production of inhibitory free fatty acids and lysophosphatidylethanolamine: absence of bacteriocins. Infect Immun. 1974 Sep;10(3):481–488. doi: 10.1128/iai.10.3.481-488.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES